Molecular and Clinical Assessment in the Treatment of AIDS Kaposi Sarcoma with Valproic Acid
Richard F. Ambinder(Johns Hopkins University), Bruce J. Dezube(Xilio Therapeutics (United States)), Susan E. Krown(Memorial Sloan Kettering Cancer Center), Jeannette Y. Lee(University of Arkansas at Little Rock), William Wachsman, MaryJo Lechowicz(Emory University), Lee Ratner(Washington University in St. Louis), Jonathan Said(University of California, Los Angeles), David M. Aboulafia(Virginia Mason Medical Center), Dirk P. Dittmer(University of North Carolina at Chapel Hill)
Cited by 0
Related Papers
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Kaposi sarcoma
|Nature Reviews Disease Primers|2019|707
Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee.
|Journal of Clinical Oncology|1989|483
Hodgkin lymphoma: A review and update on recent progress
|CA A Cancer Journal for Clinicians|2017|479
Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-Hydroperoxycyclophosphamide
|New England Journal of Medicine|1986|441